Authors: Frias, JP Macaraeg, GB Ofrecio, J Yu, JG Olefsky, JM Kruszynska, YT

Citation: Jp. Frias et al., Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women, DIABETES, 50(6), 2001, pp. 1344-1350

Authors: Frias, JP Basabe, L Macaraeg, G Kruszynska, YT

Citation: Jp. Frias et al., Lack of effect of a physiological elevation of plasma non-esterified fattyacid levels on insulin secretion, DIABETE MET, 26(2), 2000, pp. 133-139

Authors: Frias, JP Kruszynska, YT Yu, JG Olefsky, JM

Citation: Jp. Frias et al., Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects, DIABET CARE, 23(1), 2000, pp. 64-69

Authors: Kruszynska, YT Yu, JG Olefsky, JM Sobel, BE

Citation: Yt. Kruszynska et al., Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects, DIABETES, 49(4), 2000, pp. 633-639

Authors: Yu, JG Kruszynska, YT Mulford, MI Olefsky, JM

Citation: Jg. Yu et al., A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients, DIABETES, 48(12), 1999, pp. 2414-2421